News | TCT | September 15, 2022

Valentin Fuster, M.D., Ph.D., Receives Prestigious Award from Cardiovascular Research Foundation

Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System

Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System 


September 15, 2022 — The Cardiovascular Research Foundation (CRF) will honor Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award

Dr. Fuster will receive this award September 17, at the 34th annual TCT scientific symposium, sponsored by CRF. The TCT Career Achievement award recognizes Dr. Fuster’s extraordinary contributions to the field of interventional cardiology and transformation of patient care through his career endeavors, research pursuits, and mentorship of others.
“I am grateful for this award and would like to recognize all the contributors who have inspired my work,” says Dr. Fuster.
Dr. Fuster's contributions to cardiovascular medicine and the prevention and treatment of heart disease globally are unparalleled. He has 35 worldwide honorary degrees and is the most highly cited Spanish research scientist of all time, according to Google Scholar. He is an author of more than 900 scientific articles in international medical journals and has published two leading books on clinical cardiology and research. Dr. Fuster has received three of the most important awards from the National Institutes of Health and is the only cardiologist to have received the highest awards for research from the four leading international cardiology organizations: the American College of Cardiology, American Heart Association (AHA), European Society of Cardiology, and Interamerican Society of Cardiology. He recently received Thailand’s Prince Mahidol Award in the field of Medicine, and this year, the AHA established the “Valentin Fuster Award for Innovation in Science” in his honor, naming him the first recipient. 

Dr. Fuster is Editor-in-Chief of the Journal of the American College of Cardiology (JACC), which ranks among the top cardiovascular journals in the world for its scientific impact. He is a past president of both the AHA and the World Heart Federation. He the General Director of the Spanish National Center for Cardiovascular Research (CNIC).  Dr. Fuster is a member of the National Academy of Medicine, where he served as chair of the Committee on Preventing the Global Epidemic of Cardiovascular Disease, and was a Council member of the National Heart, Lung, and Blood Institute. Dr. Fuster was also President of the Training Program of the American College of Cardiology. 

For more information: https://www.mountsinai.org 

Find more TCT22 coverage here  


Related Content

News | Heart Failure

Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are ...

Home October 02, 2024
Home
News | Heart Failure

Sept. 30, 2024 — Cytokinetics, Inc. recently announced that additional analyses synthesizing data from SEQUOIA-HCM ...

Home October 02, 2024
Home
News | Heart Failure

Sept. 18, 2024 – Astellas Pharma Inc. recently announced that Digitiva, a non-invasive digital health solution for heart ...

Home September 19, 2024
Home
News | Heart Failure

Aug. 21, 2024 — The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates ...

Home August 21, 2024
Home
News | Heart Failure

July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & ...

Home July 31, 2024
Home
News | Heart Failure

July 30, 2024 — Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of ...

Home July 30, 2024
Home
News | Heart Failure

July 29, 2024 — When it comes to treating cardiac arrest, acting quickly can mean the difference between life and death ...

Home July 29, 2024
Home
News | Heart Failure

June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...

Home June 27, 2024
Home
News | Heart Failure

June 24, 2024 — Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at ...

Home June 24, 2024
Home
News | Heart Failure

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has ...

Home June 18, 2024
Home
Subscribe Now